BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Business

  CASMED Reports Third-Quarter 2016 Financial Results

  November 8, 2016

   · 

  1 min read
• Pharm Country

  Hemispherx Featured In Corporate America News Magazine Special Report “Capturing The Power Of Immune Response To Treat Disease: Biotech Bounce Back”

  November 8, 2016

   · 

  7 min read
• Drug Development

  Zosano Announces Completion Of Enrollment In Pivotal Efficacy Trial For M207 For Acute Migraine

  November 8, 2016

   · 

  4 min read
• BioCapital

  Diffusion Pharma Announces Uplisting To NASDAQ Capital Market

  November 8, 2016

   · 

  4 min read
• Business

  Lipocine Announces Financial And Operational Results For The Third Quarter Of 2016

  November 8, 2016

   · 

  1 min read
• Business

  Osiris Reports Preliminary 2014 And 2015 Revenue And Anticipated 2016 Revenue

  November 8, 2016

   · 

  3 min read
• Business

  Pernix Appoints Two Board Members

  November 8, 2016

   · 

  5 min read
• Business

  Elite Pharma To Host Conference Call To Discuss 2nd Quarter 2017 Financial Results On November 10, 2016

  November 8, 2016

   · 

  3 min read
• Business

  INC Research Selected To Manage The Leukemia & Lymphoma Society’s First-Ever Master Trial To Advance New Targeted Therapies For Acute Myeloid Leukemia

  November 8, 2016

   · 

  5 min read
• Drug Development

  Seattle Genetics And Takeda Complete Enrollment Of Phase III ECHELON-2 Clinical Trial Evaluating ADCETRIS (Brentuximab Vedotin) In Frontline Mature T-Cell Lymphoma

  November 8, 2016

   · 

  18 min read